These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 15781843)
1. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). McGee HT; Egan RA; Clark WM Neurology; 2005 Mar; 64(6):1095-6. PubMed ID: 15781843 [No Abstract] [Full Text] [Related]
2. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Hellstrom WJ Neurology; 2006 Jan; 66(2):293-4; author reply 293-4. PubMed ID: 16434684 [No Abstract] [Full Text] [Related]
3. Visual field defect as a presenting sign for hemorrhagic stroke caused by sildenafil. Mehdizadeh M; Hosseini H; Yazdchi T; Farahangiz S Indian J Ophthalmol; 2008; 56(2):159-60. PubMed ID: 18292633 [TBL] [Abstract][Full Text] [Related]
4. Intracerebral hemorrhage associated with sildenafil use: a case report. Alpsan MH; Bebek N; Ciftci FD; Coban O; Bahar S; Tuncay R J Neurol; 2008 Jun; 255(6):932-3. PubMed ID: 18465112 [No Abstract] [Full Text] [Related]
6. [Effective and safe use of Levitra (Vardenafil) for treatment of erectile dysfunction]. Mazo EB; Gamidov SI; Ovchinnikov RI Urologiia; 2004; (3):58-66. PubMed ID: 15199819 [No Abstract] [Full Text] [Related]
12. Tadalafil (Cialis) and vardenafil (Levitra) recently approved drugs for erectile dysfunction. Gaines KK Urol Nurs; 2004 Feb; 24(1):46-8. PubMed ID: 15054911 [No Abstract] [Full Text] [Related]
13. [Safety and tolerability of Vardenafil]. Hong K; Jiang H Zhonghua Nan Ke Xue; 2006 Sep; 12(9):857-60. PubMed ID: 17009542 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. van Ahlen H; Wahle K; Kupper W; Yassin A; Reblin T; Neureither M J Sex Med; 2005 Nov; 2(6):856-64. PubMed ID: 16422810 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and tolerability of vardenafil within the time window of 6 hours after administration and beyond]. Porst H; Lunglmayr G; MMW Fortschr Med; 2005 May; 147(18):43. PubMed ID: 15934588 [No Abstract] [Full Text] [Related]
16. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction]. Katsarov M Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315 [No Abstract] [Full Text] [Related]
17. [Efficacy and safety of treatment of erectile dysfunction with Vardenafil under routine conditions]. Van Ahlen H; Zumbé J; Stauch K; Landen H MMW Fortschr Med; 2005 Oct; 147(43):41. PubMed ID: 16302421 [No Abstract] [Full Text] [Related]
18. [Efficacy and safety of vardenafil for men with erectile dysfunction]. Zhu J; Jiang H Zhonghua Nan Ke Xue; 2004 Sep; 10(9):704-10. PubMed ID: 15497716 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of vardenafil in men with erectile dysfunction in general clinical practice]. Shang XJ Zhonghua Nan Ke Xue; 2005 Jul; 11(7):556-9. PubMed ID: 16078680 [TBL] [Abstract][Full Text] [Related]